Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access for Abatacept
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access for Relatlimab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Status
- RECRUITING
- Phase
- N/A
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
- Status
- COMPLETED
- Phase
- N/A